Calamos Advisors
ARCKU

Calamos Advisors’s Arbor Rapha Capital Bioholdings Corp. I Units ARCKU Stock Holding History

Calamos Advisors’s Portfolio ARCKU Stock Details ARCKU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-350,000
Closed -$3.54M – 1503
2022
Q2 		$3.54M Hold
350,000
– – 0.02% 808
2022
Q1 		$3.52M Hold
350,000
– – 0.01% 801
2021
Q4 		$3.55M Buy
+350,000
New +$3.54M 0.01% 792

Other funds holding ARCKU

HIM
HGC Investment Management Toronto, Ontario, Canada $507M AUM 6.15% 1-Year Est. Return
CCA
Castle Creek Arbitrage Avon, Colorado $425M AUM 7.4% 1-Year Est. Return
LP
LMR Partners London, United Kingdom $26.8B AUM 68.38% 1-Year Est. Return
WC
Wealthspring Capital West Harrison, New York $448M AUM 8.38% 1-Year Est. Return
YCM
Yakira Capital Management Westport, Connecticut $351M AUM 21.82% 1-Year Est. Return
SIA
Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.5B AUM 83.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
CCM
Condor Capital Management Martinsville, New Jersey $1.33B AUM 19.79% 1-Year Est. Return
AA
Ancora Advisors Cleveland, Ohio $5.19B AUM 23.19% 1-Year Est. Return

Calamos Advisors's ARCKU Position: Q3 2022 in Review

Calamos Advisors sold out of Arbor Rapha Capital Bioholdings Corp. I Units (ARCKU) in Q3 2022, closing a stake of 350,000 shares — an estimated $3.54M sold.

Calamos Advisors first reported a position in ARCKU in Q4 2021 and held it in 3 quarters. The position peaked at $3.55M in Q4 2021. 13 funds tracked by Wall St. Rank hold ARCKU as of Q3 2022.

  • Calamos Advisors reported no remaining Arbor Rapha Capital Bioholdings Corp. I Units position as of Q3 2022 after selling out during the quarter.
  • Calamos Advisors sold 350,000 Arbor Rapha Capital Bioholdings Corp. I Units shares in Q3 2022, an estimated $3.54M.
  • Calamos Advisors first reported a position in Arbor Rapha Capital Bioholdings Corp. I Units in Q4 2021 and held it in 3 quarters.
  • Calamos Advisors's Arbor Rapha Capital Bioholdings Corp. I Units position peaked at $3.55M in Q4 2021.
  • 13 funds tracked by Wall St. Rank held Arbor Rapha Capital Bioholdings Corp. I Units as of Q3 2022.

Based on Calamos Advisors's 13F filing for Q3 2022, filed 24 Oct 2022.